GlaxoSmithKline PLC (GSK) announces partnership to develop therapeutics to treat FSHD

发布日期 12 月 12th, 201212/12/12

GlaxoSmithKline PLC (GSK) announces partnership to develop therapeutics to treat FSHD. The goal of the new agreement is to develop a small-molecule-based medicine to potentially reverse FSHD